Similar Articles

• Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses

  James K. Burmester, Richard L. Berg, Ingrid Glurich, Steven H. Yale, John R. Schmelzer and Michael D. Caldwell

  • Clinical Medicine & Research November 2011, 9 (3-4) 119-124;
  • DOI: https://doi.org/10.3121/cmr.2011.951
• Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses

  James K. Burmester, Richard L. Berg, Ingrid Glurich, Steven H. Yale, John R. Schmelzer and Michael D. Caldwell

  • Clinical Medicine & Research May 2011, cmr.2011.951;
  • DOI: https://doi.org/10.3121/cmr.2011.951
• Does CALU SNP rs1043550 Contribute Variability to Therapeutic Warfarin Dosing Requirements?

  Ingrid Glurich, Richard L. Berg and James K. Burmester

  • Clinical Medicine & Research May 2013, cmr.2013.1130;
  • DOI: https://doi.org/10.3121/cmr.2013.1130
• Does CALU SNP rs1043550 Contribute Variability to Therapeutic Warfarin Dosing Requirements?

  Ingrid Glurich, Richard L. Berg and James K. Burmester

  • Clinical Medicine & Research June 2013, 11 (2) 73-79;
  • DOI: https://doi.org/10.3121/cmr.2013.1130
• A Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data

  Michael A. Hillman, Russell A. Wilke, Steven H. Yale, Humberto J. Vidaillet, Michael D. Caldwell, Ingrid Glurich, Richard L. Berg, John Schmelzer and James K. Burmester

  • Clinical Medicine & Research August 2005, 3 (3) 137-145;
  • DOI: https://doi.org/10.3121/cmr.3.3.137
• Evaluation of Genetic Factors for Warfarin Dose Prediction

  Michael D. Caldwell, Richard L. Berg, Kai Qi Zhang, Ingrid Glurich, John R. Schmelzer, Steven H. Yale, Humberto J. Vidaillet and James K. Burmester

  • Clinical Medicine & Research March 2007, 5 (1) 8-16;
  • DOI: https://doi.org/10.3121/cmr.2007.724
• Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures

  Lucas G Leonhard, Richard L Berg, James K Burmester, Joseph J Mazza, John R Schmelzer and Steven H Yale

  • Clinical Medicine & Research June 2014, cmr.2014.1208;
  • DOI: https://doi.org/10.3121/cmr.2014.1208
• Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures

  Lucas G Leonhard, Richard L Berg, James K Burmester, Joseph J Mazza, John R Schmelzer and Steven H Yale

  • Clinical Medicine & Research June 2014, cmr.2014.1208;
  • DOI: https://doi.org/10.3121/cmr.2014.1208
• Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures

  Lucas G. Leonhard, Richard L. Berg, James K. Burmester, Joseph J. Mazza, John R. Schmelzer and Steven H. Yale

  • Clinical Medicine & Research March 2015, 13 (1) 1-6;
  • DOI: https://doi.org/10.3121/cmr.2014.1208
• Warfarin Initiation and the Potential Role of Genomic-Guided Dosing

  Craig R. Lee

  • Clinical Medicine & Research November 2005, 3 (4) 205-206;
  • DOI: https://doi.org/10.3121/cmr.3.4.205

Previous

Next

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• 194